T2 Biosystems Inc. (TTOO) had a rough trading day for Friday November 22 as shares tumbled 5.52%, or a loss of $-0.09 per share, to close at $1.54. After opening the day at $1.62, shares of T2 Biosystems Inc. traded as high as $1.64 and as low as $1.45. Volume was 1.41 million shares over 2,762 trades, against an average daily volume of n/a shares and a total float of 44.54 million.
As a result of the decline, T2 Biosystems Inc. now has a market cap of $68.58 million. In the last year, shares of T2 Biosystems Inc. have traded between a range of $5.38 and $0.52, and its 50-day SMA is currently $n/a and 200-day SMA is $n/a.
T2 Biosystems Inc provides rapid in vitro diagnostic tests to hospitals and laboratories. Its core technology is the T2 Magnetic Resonance (T2MR) technology, which can detect a variety of molecular targets directly from whole blood. T2MR technology enables the T2Dx system, which is fully automated from patient sample to result for its panels focused on bacterial and fungal infections that could cause sepsis, and its pipeline panel for Lyme disease.
T2 Biosystems Inc. is based out of Lexington, MA and has some 153 employees. Its CEO is .
T2 Biosystems Inc. is a component of the Russell 2000. The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It’s maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.
Russell’s indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It’s a simple approach that gives a broad, unbiased look at the small-cap market as a whole.
